-
Je něco špatně v tomto záznamu ?
Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity
G. Bouz, L. Semelková, O. Janďourek, K. Konečná, P. Paterová, L. Navrátilová, V. Kubíček, J. Kuneš, M. Doležal, J. Zitko,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
SVV 260 401
Ministry of Education, Youth and Sports of the Czech Republic
CZ.02.1.01/0.0/0.0/16_019/0000841
EFSA-CDN co-funded by ERDF
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antibakteriální látky chemická syntéza chemie farmakologie MeSH
- antifungální látky farmakologie MeSH
- Bacteria účinky léků MeSH
- buněčná smrt účinky léků MeSH
- buňky Hep G2 MeSH
- houby účinky léků MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- molekulární konformace MeSH
- pyraziny chemická syntéza chemie farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
We report the design, synthesis, and in vitro antimicrobial activity of a series of N-substituted 3-aminopyrazine-2-carboxamides with free amino groups in position 3 on the pyrazine ring. Based on various substituents on the carboxamidic moiety, the series is subdivided into benzyl, alkyl, and phenyl derivatives. The three-dimensional structures of the title compounds were predicted using energy minimization and low mode molecular dynamics under AMBER10:EHT forcefield. Compounds were evaluated for antimycobacterial, antibacterial, and antifungal activities in vitro. The most active compound against Mycobacterium tuberculosis H37Rv (Mtb) was 3-amino-N-(2,4-dimethoxyphenyl)pyrazine-2-carboxamide (17, MIC = 12.5 μg/mL, 46 μM). Antimycobacterial activity against Mtb and M. kansasii along with antibacterial activity increased among the alkyl derivatives with increasing the length of carbon side chain. Antibacterial activity was observed for phenyl and alkyl derivatives, but not for benzyl derivatives. Antifungal activity was observed in all structural subtypes, mainly against Trichophyton interdigitale and Candida albicans. The four most active compounds (compounds 10, 16, 17, 20) were evaluated for their in vitro cytotoxicity in HepG2 cancer cell line; only compound 20 was found to exert some level of cytotoxicity. Compounds belonging to the current series were compared to previously published, structurally related compounds in terms of antimicrobial activity to draw structure activity relationships conclusions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034683
- 003
- CZ-PrNML
- 005
- 20240528080859.0
- 007
- ta
- 008
- 191007s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules24071212 $2 doi
- 035 __
- $a (PubMed)30925695
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bouz, Ghada $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. bouzg@faf.cuni.cz.
- 245 10
- $a Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity / $c G. Bouz, L. Semelková, O. Janďourek, K. Konečná, P. Paterová, L. Navrátilová, V. Kubíček, J. Kuneš, M. Doležal, J. Zitko,
- 520 9_
- $a We report the design, synthesis, and in vitro antimicrobial activity of a series of N-substituted 3-aminopyrazine-2-carboxamides with free amino groups in position 3 on the pyrazine ring. Based on various substituents on the carboxamidic moiety, the series is subdivided into benzyl, alkyl, and phenyl derivatives. The three-dimensional structures of the title compounds were predicted using energy minimization and low mode molecular dynamics under AMBER10:EHT forcefield. Compounds were evaluated for antimycobacterial, antibacterial, and antifungal activities in vitro. The most active compound against Mycobacterium tuberculosis H37Rv (Mtb) was 3-amino-N-(2,4-dimethoxyphenyl)pyrazine-2-carboxamide (17, MIC = 12.5 μg/mL, 46 μM). Antimycobacterial activity against Mtb and M. kansasii along with antibacterial activity increased among the alkyl derivatives with increasing the length of carbon side chain. Antibacterial activity was observed for phenyl and alkyl derivatives, but not for benzyl derivatives. Antifungal activity was observed in all structural subtypes, mainly against Trichophyton interdigitale and Candida albicans. The four most active compounds (compounds 10, 16, 17, 20) were evaluated for their in vitro cytotoxicity in HepG2 cancer cell line; only compound 20 was found to exert some level of cytotoxicity. Compounds belonging to the current series were compared to previously published, structurally related compounds in terms of antimicrobial activity to draw structure activity relationships conclusions.
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Bacteria $x účinky léků $7 D001419
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a houby $x účinky léků $7 D005658
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a pyraziny $x chemická syntéza $x chemie $x farmakologie $7 D011719
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Semelková, Lucia $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. lucia.semelkova@seznam.cz.
- 700 1_
- $a Janďourek, Ondřej $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. jando6aa@faf.cuni.cz.
- 700 1_
- $a Konečná, Klára $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. konecna@faf.cuni.cz.
- 700 1_
- $a Paterová, Pavla $u Department of Clinical Microbiology, Faculty Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic. pavla.paterova@fnhk.cz.
- 700 1_
- $a Navrátilová, Lucie $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. navratl2@faf.cuni.cz.
- 700 1_
- $a Kubíček, Vladimír $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. kubicek@faf.cuni.cz.
- 700 1_
- $a Kuneš, Jiří $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. kunes@faf.cuni.cz.
- 700 1_
- $a Doležal, Martin, $d 1961- $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. dolezalm@faf.cuni.cz. $7 jn19981000714
- 700 1_
- $a Zitko, Jan $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. jan.zitko@faf.cuni.cz.
- 773 0_
- $w MED00180394 $t Molecules $x 1420-3049 $g Roč. 24, č. 7 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30925695 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20240528080856 $b ABA008
- 999 __
- $a ok $b bmc $g 1451343 $s 1073233
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 24 $c 7 $e 20190328 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a SVV 260 401 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000841 $p EFSA-CDN co-funded by ERDF
- LZP __
- $a Pubmed-20191007